Source Natural Foods & Herbal Supplements Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 446660, "name": "Source Natural", "stock_name": "Source Natural", "full_name": "Source Natural Foods & Herbal Supplements Ltd", "name_url": "stocks-analysis/source-natural", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "110.90", "chg": 1.05, "chgp": "0.96%", "dir": 1, "prev_price": "109.85", "mcapval": "76.00 Cr", "mcap": "Micro Cap", "scripcode": 531398, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE679C01027", "curr_date": "Jul 17, 03:30 PM", "curr_time": "15:14 PM", "last_traded_at": "Jul 17, 03:30 PM IST", "bse_nse_vol": "280 ", "exc_status": "Active", "traded_date": "Jul 17, 2026", "traded_date_str": "2026 07 17", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/source-natural-446660-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Source Natural Foods & Herbal Supplements Ltd Upgraded to Sell on Technical Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-herbal-supplements-ltd-upgraded-to-sell-on-technical-improvements-4103271", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SourceNaturalFo_mojoScore_4103271.png", "date": "2026-07-15 08:18:37", "description": "Source Natural Foods & Herbal Supplements Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite ongoing fundamental challenges. The change, effective from 14 July 2026, is driven primarily by improvements in technical indicators, while valuation and financial trends present a mixed picture for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Source Natural Foods & Herbal Supplements Ltd Downgraded to Strong Sell Amid Technical Weakness and Mixed Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-herbal-supplements-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-mixed-fundamentals-4093027", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SourceNaturalFo_mojoScore_4093027.png", "date": "2026-07-08 08:21:10", "description": "Source Natural Foods & Herbal Supplements Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 7 July 2026. This revision reflects a deterioration in technical indicators, persistent underperformance relative to benchmarks, and concerns over the company’s long-term financial trajectory despite recent quarterly gains." }, { "title": "Source Natural Foods & Herbal Supplements Ltd Upgraded to Sell on Technical Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-herbal-supplements-ltd-upgraded-to-sell-on-technical-improvements-4087090", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SourceNaturalFo_mojoScore_4087090.png", "date": "2026-07-03 08:16:47", "description": "Source Natural Foods & Herbal Supplements Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite ongoing fundamental challenges. The change, effective from 2 July 2026, is driven primarily by improvements in technical indicators, while valuation and financial trends present a mixed picture for investors in this micro-cap pharmaceutical and biotechnology company." }, { "title": "Source Natural Foods & Herbal Supplements Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-herbal-supplements-ltd-is-rated-strong-sell-4076755", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SourceNaturalFo_mojoScore_4076755.png", "date": "2026-06-29 10:11:09", "description": "Source Natural Foods & Herbal Supplements Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 May 2026, reflecting a change from the previous 'Sell' grade. However, all fundamentals, returns, and financial metrics discussed here are current as of 29 June 2026, providing investors with the latest view of the stock's position." }, { "title": "Source Natural Foods & Herbal Supplements Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-herbal-supplements-ltd-is-rated-strong-sell-4058693", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SourceNaturalFo_mojoScore_4058693.png", "date": "2026-06-17 10:11:42", "description": "Source Natural Foods & Herbal Supplements Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 May 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 17 June 2026, providing investors with the latest view of the company’s position." }, { "title": "Source Natural Foods & Herbal Supplements Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-herbal-supplements-ltd-is-rated-strong-sell-4036586", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SourceNaturalFo_mojoScore_4036586.png", "date": "2026-06-05 10:10:55", "description": "Source Natural Foods & Herbal Supplements Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 May 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 05 June 2026, providing investors with the latest perspective on the company’s position." }, { "title": "Source Natural Foods Gains 1.52%: Valuation Shift and Q4 Results Shape Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/source-natural-foods-gains-152-valuation-shift-and-q4-results-shape-week-4023539", "imagepath": "", "date": "2026-05-30 17:12:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 25:</strong> Stock opens at Rs.107.65, declines 0.69% amid Sensex rally</p>\n <p><strong>May 26:</strong> Further dip to Rs.105.75 on increased volume, Sensex slips 0.17%</p>\n <p><strong>May 27:</strong> Sharp rebound to Rs.112.00 (+5.91%) following valuation update</p>\n <p><strong>May 29:</strong> Week closes at Rs.110.05 (-1.74%) post Q4 earnings release</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.108.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Cl..." }, { "title": "Are Source Natural Foods & Herbal Supplements Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-source-natural-foods-herbal-supplements-ltd-latest-results-good-or-bad-4021881", "imagepath": "", "date": "2026-05-29 19:46:07", "description": "Source Natural Foods & Herbal Supplements Ltd's latest financial results for Q4 FY26 reveal a complex picture of growth amidst ongoing operational challenges. The company reported net sales of ₹21.03 crores, reflecting a year-on-year growth of 30.86%, which marks the highest quarterly revenue in its recent history. However, this top-line growth has not translated into a corresponding improvement in profitability metrics. The net profit for the quarter stood at ₹1.24 crores, showing a significant sequential increase of 51.22% but yielding a profit after tax (PAT) margin of only 5.90%, which is lower than historical figures.\n\nOperating profit margins, excluding other income, improved to 10.65% from the previous quarter's 7.54%, yet this remains substantially below the 15.89% achieved in December 2024. This margin volatility indicates persistent cost management issues and pricing pressures in the competitive o..." }, { "title": "Source Natural Foods Q4 FY26: Strong Revenue Growth Masks Margin Erosion Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/source-natural-foods-q4-fy26-strong-revenue-growth-masks-margin-erosion-concerns-4020502", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SourceNaturalFo_quaterlyResult_4020502.png", "date": "2026-05-29 09:38:06", "description": "Source Natural Foods & Herbal Supplements Ltd., a Bengaluru-based pharmaceutical company specialising in organic ayurvedic formulations, reported a net profit of ₹1.24 crores for Q4 FY26, marking a sequential improvement of 51.22% from the previous quarter. However, the stock has tumbled 39.97% over the past year, significantly underperforming both the broader market and its pharmaceutical sector peers, reflecting deep investor scepticism about the company's long-term profitability trajectory." } ], "total": 250, "sid": "446660", "stock_news_url": "https://www.marketsmojo.com/news/source-natural-foods-herbal-supplements-446660" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "10-Jul-2026", "details": "Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "30-Jun-2026", "details": "Closure of Trading window for the quarter ended June 30 2026", "source": "BSE" }, { "caption": "Incorporation Of A Wholly Owned Subsidiary Company", "datetime": "19-Jun-2026", "details": "Approval for incorporation of a Wholly Owned Subsidiary Company under the name Source Natural Estates Private Limited", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 25: Stock opens at Rs.107.65, declines 0.69% amid Sensex rally

May 26: Further dip to Rs.105.75 on increased volume, Sensex slips 0.17%

May 27: Sharp rebound to Rs.112.00 (+5.91%) following valuation update

May 29: Week closes at Rs.110.05 (-1.74%) post Q4 earnings release

Week Open

Rs.108.40

Week Cl...

Read full news article

Are Source Natural Foods & Herbal Supplements Ltd latest results good or bad?

2026-05-29 19:46:07

Source Natural Foods & Herbal Supplements Ltd's latest financial results for Q4 FY26 reveal a complex picture of growth amidst ongoing operational challenges. The company reported net sales of ₹21.03 crores, reflecting a year-on-year growth of 30.86%, which marks the highest quarterly revenue in its recent history. However, this top-line growth has not translated into a corresponding improvement in profitability metrics. The net profit for the quarter stood at ₹1.24 crores, showing a significant sequential increase of 51.22% but yielding a profit after tax (PAT) margin of only 5.90%, which is lower than historical figures. Operating profit margins, excluding other income, improved to 10.65% from the previous quarter's 7.54%, yet this remains substantially below the 15.89% achieved in December 2024. This margin volatility indicates persistent cost management issues and pricing pressures in the competitive o...

Read full news article

Source Natural Foods Q4 FY26: Strong Revenue Growth Masks Margin Erosion Concerns

2026-05-29 09:38:06

Source Natural Foods & Herbal Supplements Ltd., a Bengaluru-based pharmaceutical company specialising in organic ayurvedic formulations, reported a net profit of ₹1.24 crores for Q4 FY26, marking a sequential improvement of 51.22% from the previous quarter. However, the stock has tumbled 39.97% over the past year, significantly underperforming both the broader market and its pharmaceutical sector peers, reflecting deep investor scepticism about the company's long-term profitability trajectory.

Read full news article